Zobrazeno 1 - 10
of 57
pro vyhledávání: '"S M, Harman"'
Publikováno v:
Clinical Radiology. 77:345-351
To characterise image-guided procedures performed near the end of life and the use of goals of care discussions (GOC) and palliative care consultation (PCC) prior to these procedures.Retrospective chart review of 3,714 consecutive inpatient procedure
Autor:
Carey E. Gleason, Virginia M. Miller, Eliot A. Brinton, Marcelle I. Cedars, Hugh S. Taylor, Juliana M. Kling, JoAnn E. Manson, S. M. Harman, Kejal Kantarci, N. M. Dowling, Frederick Naftolin
Publikováno v:
Climacteric
The Kronos Early Estrogen Prevention Study (KEEPS) was a randomized, double-blind, placebo-controlled trial designed to determine the effects of hormone treatments (menopausal hormone treatments; MHT) on the progression of carotid intima-medial thick
Autor:
H. S. Taylor, A. Tal, L. Pal, F. Li, D. M. Black, E. A. Brinton, M. J. Budoff, M. I. Cedars, W. Du, H. N. Hodis, R. A. Lobo, J. E. Manson, G. R. Merriam, V. M. Miller, F. Naftolin, G. Neal-Perry, N. F. Santoro, S. M. Harman
Publikováno v:
Family Medicine; № 6 (74) (2017); 110-117
Семейная медицина; № 6 (74) (2017); 110-117
Сімейна медицина; № 6 (74) (2017); 110-117
Семейная медицина, Vol 0, Iss 6 (74), Pp 110-117 (2017)
Семейная медицина; № 6 (74) (2017); 110-117
Сімейна медицина; № 6 (74) (2017); 110-117
Семейная медицина, Vol 0, Iss 6 (74), Pp 110-117 (2017)
Сексуальная дисфункция является важной детерминантой здоровья и качества жизни женщин и обычно связана со снижением уровня эстрогенов
Autor:
S M Harman, Sharon L. Mulvagh, B. A. Lahr, Virginia M. Miller, Kent R. Bailey, Juliana M. Kling
Publikováno v:
Climacteric
Objective Endothelial dysfunction occurs early in the atherosclerotic disease process, often preceding clinical symptoms. Use of menopausal hormone treatment (MHT) to reduce cardiovascular risk is controversial. This study evaluated effects of 4 year
Autor:
Aileen P. McGinn, Matthew J. Budoff, Irfan Zeb, Unab I. Khan, Virginia M. Miller, Marcelle I. Cedars, Howard N. Hodis, Hugh S. Taylor, Eliot A. Brinton, JoAnn E. Manson, Rachel P. Wildman, Alexandra D. Ogorodnikova, Nanette Santoro, Frederick Naftolin, Rogerio A. Lobo, George R. Merriam, S M Harman
Publikováno v:
Obesity. 21:1726-1733
Objective It is unclear why despite a comparable cardiometabolic risk profile, “metabolically benign” overweight/obese individuals show an elevated risk of cardiovascular disease compared to normal weight individuals. Design and Methods In cross-
Publikováno v:
Hormone and Metabolic Research. 40:199-205
Aging diminishes hormone secretion and target cell responsiveness, possibly due to loss of cell membrane fluidity or alteration of membrane phospholipids affecting signal transduction. We investigated whether a high omega-3 polyunsaturated fatty acid
Autor:
Muthuvel Jayachandran, Brian D. Lahr, Kent R. Bailey, John A. Heit, Virginia M. Miller, S M Harman
Publikováno v:
The FASEB Journal. 29
Autor:
Roger A. Lobo, Marcelle I. Cedars, Frederick Naftolin, Virginia M. Miller, Eliot A. Brinton, George R. Merriam, JoAnn E. Manson, S. M. Harman, Nanette Santoro
Publikováno v:
Climacteric. 8:3-12
Observational studies have indicated that hormone therapy given at or after menopause is linked to substantial reduction in cardiovascular disease and its risk factors. Recent findings from the Women's Health Initiative (WHI) clinical trial, however,
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:4108-4112
Weight loss is commonly associated with increased morbidity and mortality in individuals with human immunodeficiency virus (HIV) infection. We performed a nested case-control study of 26 HIV-infected subjects recruited from a cohort of gay men enroll
Autor:
A. J. Ryan, S. M. Harman, Marc A. Rogers, B. J. Nicklas, Marc R. Blackman, B. F. Hurley, M. M. Treuth
Publikováno v:
International Journal of Sports Medicine. 16:445-450
We investigated the responses of serum testosterone (T) and human growth hormone (hGH) concentrations to a bout of heavy resistive exercise and the responses of T, hGH, and insulin-like growth factor I (IGF-I) to a 16 wk progressive resistive trainin